84265人已查看 《MEDICAL MICROBIOLOGY AND IMMUNOLOGY》 期刊2026最新IF预测值
预警说明
查看说明
时间
预警情况
2025年03月发布的2025版
不在预警名单中
2024年02月发布的2024版
不在预警名单中
2023年01月发布的2023版
不在预警名单中
2021年12月发布的2021版
不在预警名单中
2020年12月发布的2020版
不在预警名单中
2026年预警名单预测
无异常数据 期刊预警概率很低
结果仅供参考
*来源:中科院《 国际期刊预警名单》
中科院分区
查看说明
版本
大类学科
小类学科
Top期刊
综述期刊
2025年3月最新升级版
医学2区
IMMUNOLOGY
免疫学2区
MICROBIOLOGY
微生物学2区
否
否
2023年12月升级版
医学3区
IMMUNOLOGY
免疫学3区
MICROBIOLOGY
微生物学3区
否
否
2022年12月旧的升级版
医学2区
IMMUNOLOGY
免疫学3区
MICROBIOLOGY
微生物学3区
否
否
JCR分区
WOS分区等级:Q3区
版本
按学科
分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of
Science)为每个学科内的期刊按照IF数值排序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
IMMUNOLOGY
Q3
测一测你投这本期刊的成功率
【官方推荐】国内首个期刊投稿预测系统,多维度分析投稿成功率,助你精准决策
12969
人已预测
期刊介绍
Medical Microbiology and Immunology (MMIM) publishes key findings on all aspects of the interrelationship between infectious agents and the immune system of their hosts. The journal´s main focus is original research work on intrinsic, innate or adaptive immune responses to viral, bacterial, fungal and parasitic (protozoan and helminthic) infections and on the virulence of the respective infectious pathogens.MMIM covers basic, translational as well as clinical research in infectious diseases and infectious disease immunology. Basic research using cell cultures, organoid, and animal models are welcome, provided that the models have a clinical correlate and address a relevant medical question.The journal also considers manuscripts on the epidemiology of infectious diseases, including the emergence and epidemic spreading of pathogens and the development of resistance to anti-infective therapies, and on novel vaccines and other innovative measurements of prevention.The following categories of manuscripts will not be considered for publication in MMIM:submissions of preliminary work, of merely descriptive data sets without investigation of mechanisms or of limited global interest,manuscripts on existing or novel anti-infective compounds, which focus on pharmaceutical or pharmacological aspects of the drugs,manuscripts on existing or modified vaccines, unless they report on experimental or clinical efficacy studies or provide new immunological information on their mode of action,manuscripts on the diagnostics of infectious diseases, unless they offer a novel concept to solve a pending diagnostic problem,case reports or case series, unless they are embedded in a study that focuses on the anti-infectious immune response and/or on the virulence of a pathogen.